Spots Global Cancer Trial Database for The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
Official Title:
Study ID: NCT01080170
Conditions
Interventions
Study Description
Brief Summary: This study explores how aromatase inhibitor therapy affects risk factors for heart disease in postmenopausal women with breast cancer.
Detailed Description:
Eligibility
Minimum Age: 60 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
University of Pittsburgh, Department of Medicine., Pittsburgh, Pennsylvania, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
